Methionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis

Dan He; Huijin Feng; Belen Sundberg; Jiaxing Yang; Justin L. Powers; Alec H. Christian; John E. Wilkinson; Cian Monnin; Daina Avizonis; Craig J. Thomas; Richard A. Friedman; Michael D. Kluger; Michael A. Hollingsworth; Paul M. Grandgenett; Kelsey Klute; Dean Toste; Christopher J Chang; Iok In Christine Chio

doi:10.1016/j.molcel.2022.06.005

Related publications

Article2008

Use of a proteomic approach to link pyruvate kinase M2 expression to oxaliplatin resistance in colorectal cancer patients and human cell lines

Àngels Ginés, Eva Martinez‐Balibrea, Carmen Plasencia, Anna Martínez‐Cardús, Eva Musulen, Nouri Neamati, J.L. Manzano, A. Abad

Article2011

Pyruvate Kinase M2 Is a PHD3-Stimulated Coactivator for Hypoxia-Inducible Factor 1

Weibo Luo, Hongxia Hu, Ryan Chang, Jun Zhong, Matthew Knabel, Robert N. O’Meally, Robert N. Cole, Akhilesh Pandey, Gregg L. Friedman

Article2019

Regulation of T cell activation and pathogenicity by dimeric pyruvate kinase M2 (PKM2)

Stefano Angiari, Caroline E. Sutton, Marah C. Runtsch, Eva M. Pålsson‐McDermott, Kingston H. G. Mills, Luke O'neill

The Journal of Immunology

Article2009

A proteomic approach links decreased pyruvate kinase M2 expression to oxaliplatin resistance in patients with colorectal cancer and in human cell lines

Eva Martinez‐Balibrea, Carmen Plasencia, Alba Ginés, Anna Martínez‐Cardús, Eva Musulen, Rodrigo Aguilera, José Luís Manzano, Nouri Neamati, Albert Abad

Article2019

Pharmacological Activation of Pyruvate Kinase M2 Inhibits CD4+ T Cell Pathogenicity and Suppresses Autoimmunity

Stefano Angiari, Marah C. Runtsch, Caroline E. Sutton, Eva M. Pålsson‐McDermott, Beth Kelly, Nisha Rana, Harry Kane, Gina Papadopoulou, Erika L. Pearce, Kingston H. G. Mills, Luke O'neill

Cell Metabolism